Financial Health Assessment: CP EXPRESS LIMITED

1. Financial Health Score: D+

Explanation: CP EXPRESS LIMITED exhibits symptoms of chronic financial deterioration. While the company maintains positive net assets and isn't facing immediate insolvency, there has been a significant decline in overall financial health since 2020, with the most recent year showing continued erosion of shareholder value. The business appears to be in a state of slow decline, with minimal trading activity and recurring losses draining reserves.

2. Key Vital Signs

💓 Net Assets (The "Heartbeat")

Interpretation: The patient suffered a near-fatal event in FY2021, losing over 60% of its net asset value. While there was a modest recovery through to 2024, the latest year shows renewed decline. Net assets are now less than half their 2020 peak — the financial "blood pressure" remains dangerously low compared to historical norms.

🫁 Cash Position (The "Lung Capacity")

• Cash has remained static at £100,000 since 2022 (down from £130,847 in 2021 and £423,301 in 2016)
• Cash represents only 21.5% of net assets
• No evidence of cash generation from operations

Interpretation: The company is breathing, but barely. Static cash levels over multiple years with no growth suggest the business is not generating organic cash flow — it is surviving on reserves rather than thriving on revenue.

🩸 Liquidity (Current Ratio)

Interpretation: On the surface, liquidity appears exceptionally strong. However, this is misleading — the high ratio is driven by low liabilities rather than strong current assets. The composition of current assets is concerning (see below).

🧬 Asset Composition (The "Body Composition")

Interpretation: This is the most concerning vital sign. "Other Debtors" of £231,375 represents an enormous proportion of current assets and has remained stubbornly static. This could represent: - Loans to related parties or the director - Unpaid share capital calls - Other inter-company balances

Without clarity on recoverability, this is a significant financial tumour — it may be inflating the asset base without real substance.

🌡️ Profitability (The "Temperature")

Interpretation: The company is running a fever — it recorded a loss of approximately £36,000 in FY2025. With no turnover disclosed (filleted accounts) and only one employee (the director), this appears to be a business with minimal or no trading activity, incurring administrative costs that exceed any revenue.

3. Diagnosis

Primary Conditions Identified:

1. Severe Financial Atrophy (Post-2020 Event) The catastrophic 61% decline in net assets between 2020 and 2021 indicates a major financial event — likely a large write-off, bad debt, or significant distribution. The company has never recovered to its pre-2021 health levels and is now declining again.

2. Dormant-Like Trading Activity With only one employee (the director), minimal trade debtors (£11,139), and no turnover disclosed, the company appears to be operating at near-dormant levels. The SIC code (66110 - Administration of financial markets) suggests financial services activity, but there's little evidence of active trading.

3. Unexplained "Other Debtors" Concentration The £231,375 in "Other Debtors" is disproportionately large and has barely moved year-on-year (£230,781 in 2024). This concentration risk suggests potential related-party balances that may not be recoverable, effectively creating a financial blockage in the asset base.

4. Called-Up Share Capital Not Paid (£149,400) This represents shares that have been issued but for which payment has not been received. While legally owed to the company, it indicates the shareholders (effectively the sole director) have not funded their capital commitments. This is an unhealthy circulatory pattern — capital that should be flowing into the business remains outstanding.

5. Chronic Loss-Making The P&L reserve has declined by £35,979, indicating the company is spending more than it earns. With minimal revenue activity, overhead costs (accountancy, filing, taxes) are eroding reserves.

Secondary Observations:

• Governance Risk: Sole director with >75% control creates significant key-person dependency and limited oversight
• No Long-Term Liabilities: While this reduces risk, it also suggests no external investment or financing activity
• Tax Liabilities Increasing: Tax and social security liabilities rose from £13,150 to £16,439, potentially indicating Corporation Tax on earlier profits or accumulating PAYE/NI obligations
• Accruals Doubled: From £5,000 to £10,000 — likely professional fees (accountancy/audit) building up

4. Prognosis

Short-term (6-12 months): ⚠️ Stable but Fragile

The company has sufficient assets to meet its minimal liabilities and is not at immediate risk of insolvency. However, continued losses will gradually erode the asset base.

Medium-term (1-3 years): 📉 Declining

Without a return to profitable trading or a strategic intervention, the company will continue to haemorrhage value. At the current loss rate of ~£36,000/year, the P&L reserve would be eliminated within approximately 8-9 years — though the trajectory could accelerate.

Long-term (3-5 years): 🔴 Critical if Unaddressed

The combination of near-dormant trading, unexplained large debtor balances, and ongoing losses creates a trajectory toward financial failure unless the business model is revitalised.

5. Recommendations

🏥 Immediate Treatment (Within 3 months)

1. Investigate "Other Debtors": The director must provide a full breakdown of the £231,375 other debtors balance. Determine: - Who owes this money? - Is it related to the director or connected parties? - What is the likelihood and timeline of recovery? - Should an impairment provision be recognised?

2. Collect Unpaid Share Capital: The £149,400 of called-up share capital not paid represents a significant outstanding amount. The director should either: - Pay the outstanding amount to inject capital, or - Cancel the unpaid shares and reduce share capital formally

3. Review Tax Position: With increasing tax liabilities and no visible revenue, ensure the company is meeting all HMRC obligations and that tax provisions are adequate.

💊 Medium-term Therapy (3-12 months)

4. Strategic Business Review: Given the SIC code (financial markets administration) and near-dormant activity, the director should decide: - Is there a viable business model to pursue? - Should the company be actively traded or formally made dormant? - Could the company be used for a new venture, or should it be dissolved?

5. Cost Reduction: If trading is to remain minimal, reduce overheads to the absolute minimum to slow the bleeding of reserves. Negotiate lower professional fees, consider whether the registered office is cost-effective.

6. Consider Voluntary Strike-Off: If the company has no active trading purpose and the director does not intend to revive it, a voluntary dissolution may be the most efficient outcome, releasing any remaining value after settling all liabilities.

🏋️ Long-term Wellness Plan (12+ months)

7. If Continuing to Trade: Develop a clear business plan with revenue targets, cost controls, and a path to profitability. The company needs a rehabilitation programme — measurable milestones to return to financial health.

8. Governance Enhancement: Even as a sole-director company, consider appointing an additional director or advisor to provide oversight and strategic challenge. This reduces key-person risk and improves decision-making quality.

9. Monitor Key Ratios Quarterly: Track the current ratio, cash position, and P&L reserve movement. Set thresholds below which action must be taken (e.g., if net assets fall below £300,000, initiate formal review).

Summary Risk Matrix